openPR Logo
Press release

Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 | Growing CAGR of 5.1%

03-18-2024 01:52 PM CET | Health & Medicine

Press release from: Allied Market Research (AMR)

/ PR Agency: Allied Market Research (AMR)
Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1

The global epilepsy devices market isx experiencing a remarkable surge, poised to exceed a valuation of $1.1 billion by 2031, as revealed by the latest market analysis. According to the report released by Allied Market Research, the market was valued at $675.23 million in 2021 and is projected to grow at a CAGR of 5.1% from 2022 to 2031.


๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐…๐จ๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ: https://www.alliedmarketresearch.com/request-sample/A14821


Epilepsy devices play a critical role in seizure detection and monitoring, offering hope and improved quality of life for millions affected by epilepsy worldwide. With advancements in technology, including deep brain stimulation (DBS), vagus nerve stimulation (VNS), and responsive neurostimulation (RNS), coupled with innovative wearable and conventional devices, the landscape of epilepsy management is rapidly evolving.

Epilepsy Devices Market Trends are rise in the geriatric population who are more susceptible to developing neurological diseases, a rise in the adoption of technologically advanced epilepsy devices, and an increase in awareness toward the benefits of using epilepsy devices in the effective diagnosis of seizures. For instance, according to National Health Service, epilepsy starts in people aged over 60 years. Furthermore, cryptogenic or stroke-related seizures are most common in elderly people.


๐Š๐ž๐ฒ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐Ÿ๐ซ๐จ๐ฆ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:

โ—‰ ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐€๐๐ฏ๐š๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ๐ฌ: The market showcases a diverse range of products, including conventional and wearable devices, EEG, Electrocardiography (EKG), Surface Electromyography (sEMG), Video Detection Systems, and more, catering to varied patient needs.

โ—‰ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ฒ๐ง๐š๐ฆ๐ข๐œ๐ฌ: With a forecast period spanning from 2021 to 2031, the report provides a comprehensive analysis of market dynamics, identifying key drivers, restraints, and opportunities shaping the epilepsy devices market.

โ—‰ ๐†๐ฅ๐จ๐›๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค: Major countries in each region are mapped based on their revenue contribution to the global market, providing valuable insights for stakeholders worldwide.

โ—‰ ๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž: Key market players such as Medpage Ltd, Abbott Laboratories, Empatica, Inc., Natus Medical Incorporated, and others are positioned strategically, enabling benchmarking and fostering a deeper understanding of market dynamics.


๐„๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐๐ž๐Ÿ๐จ๐ซ๐ž ๐๐ฎ๐ฒ๐ข๐ง๐ : https://www.alliedmarketresearch.com/purchase-enquiry/A14821


๐‹๐ž๐š๐๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ-

โ— Cadwell Industries

โ— Natus Medical Compumedics Limited

โ— Empatica Inc.

โ— LivaNova PLC

โ— Masimo Corporation

โ— Medpage Ltd.

โ— Medtronic plc

โ— Boston Scientific Corporation

โ— Abbott Laboratories


๐’๐ญ๐š๐ค๐ž๐ก๐จ๐ฅ๐๐ž๐ซ๐ฌ ๐’๐ญ๐š๐ง๐ ๐ญ๐จ ๐๐ž๐ง๐ž๐Ÿ๐ข๐ญ ๐Ÿ๐ซ๐จ๐ฆ:

โ—‰ Quantitative analysis of market segments and current trends

โ—‰ Insights into prevailing market opportunities

โ—‰ Porter's five forces analysis for profit-oriented business decisions

โ—‰ Identification of key growth strategies and application areas

With an emphasis on innovation and patient-centric care, the epilepsy devices market is poised for significant growth, revolutionizing epilepsy management globally.

๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ, ๐‘๐ž๐ฌ๐ญ๐ซ๐š๐ข๐ง๐ญ๐ฌ, ๐š๐ง๐ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ-

Rise in the prevalence of old age population that are more vulnerable to epilepsy and increase in awareness regarding the use of epilepsy devices drives the growth of the global epilepsy devices market. On the other hand, strict government regulations concerning the manufacturing of epilepsy device products and product approvals impede the growth to some extent. However, increase in focus on developing cost-effective epilepsy devices and surge in R&D investments in the discovery & development of advanced epilepsy devices are expected to create lucrative opportunities in the industry.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

David Correa

Portland, OR, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 | Growing CAGR of 5.1% here

News-ID: 3434530 • Views: โ€ฆ

More Releases from Allied Market Research (AMR)

Prepreg Market Analysis: Navigating Growth Trends and Forecast from 2026 to 2031
Prepreg Market Analysis: Navigating Growth Trends and Forecast from 2026 to 2031
According to a recent report published by Allied Market Research, titled "Prepreg Market by Fiber Type, Resin Type, Manufacturing Process, End User Industry: Global Opportunity Analysis and Industry Forecast, 2021-2031," the global prepreg market was valued at $6.3 billion in 2021 and is projected to reach $16.1 billion by 2031, registering a CAGR of 9.9% from 2022 to 2031. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A11471 Market Drivers and Growth Opportunities: - Theโ€ฆ
Polysulfone Market Insights, Growth Trends and Forecast from 2026 to 2031
Polysulfone Market Insights, Growth Trends and Forecast from 2026 to 2031
The rapid development of advanced polymer processing technologies such as extrusion, injection molding, and 3D printing has significantly simplified the manufacturing of high-performance polysulfone components. These advancements are expanding the adoption of polysulfone across a broader range of applications, from healthcare and electronics to automotive and aerospace industries. According to a report published by Allied Market Research, titled "Polysulfone Market by Type, Grade, Application, End User Industry, and Region: Global Opportunityโ€ฆ
Polyester Fiber Market Analysis, Growth Drivers and Forecast from 2026 to 2032
Polyester Fiber Market Analysis, Growth Drivers and Forecast from 2026 to 2032
According to the study, the global polyester fiber market was valued at $81.1 billion in 2022 and is projected to reach $160.1 billion by 2032, registering a CAGR of 7.1% from 2023 to 2032. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A10583 Key Growth Drivers and Market Dynamics: - The growth of the global polyester fiber market is primarily driven by surging demand from the textile and home furnishing industries, along with the rapidโ€ฆ
Polyurethane Sealant Market Trends and Growth Outlook, Projections from 2026 to 2032
Polyurethane Sealant Market Trends and Growth Outlook, Projections from 2026 to โ€ฆ
The global polyurethane sealant market is witnessing steady growth, primarily driven by rising demand from the construction sector. The construction industry remains one of the largest consumers of polyurethane sealants, owing to their extensive use in bonding, sealing, and gap-filling applications. Rapid economic growth, increasing urbanization, and expanding residential, commercial, and infrastructure development projects across the globe are significantly boosting market demand. The global polyurethane sealant market was valued at $3.0โ€ฆ

All 5 Releases


More Releases for Epilepsy

Gavin Hogarth Shares a Personal and Informative Perspective on Living With Epile โ€ฆ
Image: https://www.globalnewslines.com/uploads/2026/01/1769444744.jpg Liverpool, England - Author Gavin Hogarth offers a candid and educational look into life with epilepsy in his book, Epilepsy, What Is It? [https://www.amazon.com/Epilepsy-What-Gavin-Hogarth/dp/1836152698/ref] Drawing from his own lived experience, Hogarth shares how the condition has shaped, challenged, and changed his life, while providing practical insight for readers seeking to better understand epilepsy. Written with honesty and purpose, Epilepsy, What Is It? aims to raise awareness and educate those whoโ€ฆ
Adult mitochondrial epilepsy presentation
Mitochondrial epilepsy is a rare but severe neurological condition caused by genetic mutations that impair mitochondrial function, disrupting cellular energy production in the brain. Patients often present with seizures, developmental delays, and neurodegeneration. It is closely associated with broader mitochondrial diseases such as MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes) and Leigh syndrome. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72869 Due to its rarity and complexity, treatment optionsโ€ฆ
Portable Epilepsy Monitoring Market in 2025
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Portable Epilepsy Monitoring Market- (By Product Type (Device Type (Chest Sensor, Watch Sensor, Monitors, Cameras, Mattresses and Pillows, and Others) and Service), By End User (Hospitals, Ambulatory Surgery Centres & Clinics, Neurology Centres, and Home Care Settings)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Globalโ€ฆ
Top 10 Epilepsy Companies Analysis (2024)
Epilepsy also known as seizure disorder, is a chronic noncommunicable disease that affects brain. Epilepsy affects people of all races, ethnic backgrounds, genders, and ages. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00016405/?utm_source=OpenPR&utm_medium=10129 Major Companies operating in the Epilepsy Market are: โ€ข Idexx Laboratories Inc. โ€ข PBD Biotech Ltd โ€ข Thermo Fisher Scientific Inc. โ€ข Innovative Diagnostics SAS โ€ข Neogen Corp โ€ข Enfer Labs โ€ข bioMerieux SA โ€ข Ring Biotechnology Co Ltd โ€ข Bionote Inc. โ€ข Shenzhen Bioeasy Biotechnology Co Ltd. Contact Us: If you have any queries about this report or ifโ€ฆ
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market - Breaking the Sei โ€ฆ
Newark, New Castle, USA: The "Epilepsy with Myoclonic-Atonic Seizures Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market: https://www.growthplusreports.com/report/epilepsy-with-myoclonic-atonic-seizures-therapeutics-market/8029 Thisโ€ฆ
Rising Instances of Pediatric Epilepsy to Pave Novel Growth Avenues in Epilepsy โ€ฆ
Owing to large scale prevalence of epilepsy cases, inclusive of pediatric epilepsy, the market for epilepsy drugs is likely to remain agile in the coming years. Prevalent amongst both male and female demographics alike, epilepsy is a critical condition that affects the brain both partially as well as in whole. Lucrative reimbursement policies, coupled with growing patient awareness about novel therapeutics are likely to reflect favorably on the growth curveโ€ฆ